Access cutting-edge hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access hypertrophic cardiomyopathy specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertrophic cardiomyopathy treatment provided free
The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compared to placebo.
Sponsor: Lexicon Pharmaceuticals
Check if you qualify for this hypertrophic cardiomyopathy clinical trial in Baltimore, MD
If you're searching for hypertrophic cardiomyopathy treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.